Tezspire
Tezspire is a prescription medicine used to treat the symptoms of Severe Asthma. Tezspire may be used alone or with other medications.
Tezepelumab-ekko, a thymic stromal lymphopoietin (TSLP) blocker, is a human monoclonal antibody immunoglobulin G2λ (IgG2λ) produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. Tezepelumab-ekko has a molecular weight of approximately 147 kDa.
Tezspire Info
The recommended dosage of TEZSPIRE is 210 mg administered subcutaneously once every 4 weeks.
Intravenous
Minutes
4
Weeks
Tezspire Side Effects
The most common side effects include:
- sore throat,
- back pain,
- joint stiffness or pain, and
- injection site reactions (redness, swelling, pain, and hard lump)
Patient Assistance Programs
There are several programs patients can sign up for that will assist in treatment costs:
Resources
To learn more about this treatment, browse the resources below.
Ready to get started?
Contact us to chat with one of our helpful scheduling specialists!